Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaella Mondola

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Opioid Management|September 21, 2018
Are physicians fully aware of the potential transgenerational and multigenerational effects of a large opioid misuse in the population?Maurizio Coppola, Raffaella Mondola
Drug Research|May 20, 2020
Potential Unconventional Medicines for the Treatment of SARS-CoV-2Maurizio Coppola, Raffaella Mondola
Journal of Opioid Management|October 7, 2017
Opioid receptor antagonists in the treatment of pathological gamblingMaurizio Coppola, Raffaella Mondola
Clinical Nutrition (Edinburgh, Scotland)|May 22, 2017
Correlation between plasma homocysteine levels and craving in alcohol dependent stabilized patientsMaurizio Coppola, Raffaella Mondola
Journal of Psychoactive Drugs|June 8, 2018
Impulsivity in Alcohol-Dependent Patients with and without ADHD: The Role of AtomoxetineMaurizio Coppola, Raffaella Mondola
Nordic Journal of Psychiatry|August 24, 2011
Potential action of betel alkaloids on positive and negative symptoms of schizophrenia: a reviewMaurizio Coppola, Raffaella Mondola
Journal of Opioid Management|December 11, 2014
MT-45: a new, dangerous legal highMaurizio Coppola, Raffaella Mondola
Drug and Alcohol Review|October 11, 2014
AH-7921: a new synthetic opioid of abuseMaurizio Coppola, Raffaella Mondola
Medical Hypotheses|December 1, 2020
Opioid receptor antagonists and major depressive disorder: Current knowledge and future perspectivesMaurizio Coppola, Raffaella Mondola
Journal of Psychoactive Drugs|April 26, 2017
JWH-122 Consumption Adverse Effects: A Case of Hallucinogen Persisting Perception Disorder Five-Year Follow-UpMaurizio Coppola, Raffaella Mondola
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Opioid Management|September 21, 2018
Are physicians fully aware of the potential transgenerational and multigenerational effects of a large opioid misuse in the population?Maurizio Coppola, Raffaella Mondola
Drug Research|May 20, 2020
Potential Unconventional Medicines for the Treatment of SARS-CoV-2Maurizio Coppola, Raffaella Mondola
Journal of Opioid Management|October 7, 2017
Opioid receptor antagonists in the treatment of pathological gamblingMaurizio Coppola, Raffaella Mondola
Clinical Nutrition (Edinburgh, Scotland)|May 22, 2017
Correlation between plasma homocysteine levels and craving in alcohol dependent stabilized patientsMaurizio Coppola, Raffaella Mondola
Journal of Psychoactive Drugs|June 8, 2018
Impulsivity in Alcohol-Dependent Patients with and without ADHD: The Role of AtomoxetineMaurizio Coppola, Raffaella Mondola
Nordic Journal of Psychiatry|August 24, 2011
Potential action of betel alkaloids on positive and negative symptoms of schizophrenia: a reviewMaurizio Coppola, Raffaella Mondola
Journal of Opioid Management|December 11, 2014
MT-45: a new, dangerous legal highMaurizio Coppola, Raffaella Mondola
Drug and Alcohol Review|October 11, 2014
AH-7921: a new synthetic opioid of abuseMaurizio Coppola, Raffaella Mondola
Medical Hypotheses|December 1, 2020
Opioid receptor antagonists and major depressive disorder: Current knowledge and future perspectivesMaurizio Coppola, Raffaella Mondola
Journal of Psychoactive Drugs|April 26, 2017
JWH-122 Consumption Adverse Effects: A Case of Hallucinogen Persisting Perception Disorder Five-Year Follow-UpMaurizio Coppola, Raffaella Mondola
Pageof 3